SRRT (serrate, RNA effector molecule) functions as a critical adapter protein at the nexus of RNA polymerase II transcription and RNA processing. SRRT mediates interactions between the cap-binding complex (CBC) and primary miRNA processing machinery by binding capped RNAs through its association with CBC component NCBP1 1. This positions SRRT as a molecular hub orchestrating competitive protein exchanges that determine RNA fate 2. SRRT plays dual roles in transcriptional regulation: it enables spliceosome recruitment to prevent premature transcript termination in embryonic stem cells, sustaining pluripotency 3, while also promoting neural stem cell self-renewal through SOX2 promoter regulation. SRRT contributes to RNA quality control by protecting functional transcripts from decay factors while allowing degradation of non-functional RNAs 4. Disease relevance includes prostate cancer, where high SRRT expression correlates with poor prognosis, higher Gleason scores, and genomic aberrations (PTEN loss, TP53 mutations) 5. SRRT is also implicated in Type 2 Diabetes through interaction with the T2D-GWAS gene JAZF1 6 and serves as a diagnostic biomarker in head and neck squamous cell carcinoma 7. Despite broad functional importance in cell proliferation and differentiation, SRRT candidate disease variants in inherited disorders await confirmation 8.